The involvement of PI3K-AKT in the growth and development of various cancer cells is accepted, as is the irregular PI3K-AKT expression in breast cancer and the pivotal role of PI3K inhibitors in targeted breast cancer therapy. Here, AKT1 is linked to breast carcinoma.